Senate Files

Bills

H.R. 5539 118th Congress

ORPHAN Cures Act

Latest action, Dec 17, 2024: Referred to the Subcommittee on Health.

How the Senate voted

The Senate hasn't taken a roll call on this bill in the Congresses covered.

13 cosponsors

Sponsored by Rep. Joyce, John [R-PA-13] (Republican). Cosponsors by party, House members included:

  • Democrats
  • Republicans
  • Independents
Cosponsors
7 D · 6 R

Referred to: House: Energy and Commerce Committee; House: Ways and Means Committee

Who lobbied on it

Clients whose quarterly lobbying reports named it, each quarter.

39 clientsQ3 2023Q4 2024

The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.

ACADIA PHARMACEUTICALS
6 reports
ASTRAZENECA PHARMACEUTICALS LP
6 reports
BIOGEN
6 reports
BIOTECHNOLOGY INNOVATION ORGANIZATION
6 reports
NOVARTIS
6 reports
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
6 reports
PTC THERAPEUTICS, INC.
6 reports
TAKEDA PHARMACEUTICALS AMERICA INC
6 reports
ASTRAZENECA PHARMACEUTICALS LP
W STRATEGIES, LLC
5 reports
DAIICHI SANKYO INC
5 reports
GSK (FKA GLAXOSMITHKLINE INC.)
5 reports
HEALTHCARE INSTITUTE OF NEW JERSEY
5 reports
JOHNSON & JOHNSON SERVICES INC
5 reports
RARE DISEASE COMPANY COALITION
THE KPM GROUP DC LLC
5 reports
AARP
4 reports
All 25 of 55 clients
ClientLobbying firmReportsReports totalingFromToSenate
ACADIA PHARMACEUTICALS6$1.9MQ4 2023Q3 2024yes
ASTRAZENECA PHARMACEUTICALS LP6$4.7MQ4 2023Q3 2024yes
BIOGEN6$6.2MQ4 2023Q3 2024yes
BIOTECHNOLOGY INNOVATION ORGANIZATION6$11.1MQ4 2023Q3 2024yes
NOVARTIS6$8.3MQ4 2023Q3 2024yes
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA6$43.8MQ4 2023Q3 2024yes
PTC THERAPEUTICS, INC.6$1.1MQ4 2023Q3 2024yes
TAKEDA PHARMACEUTICALS AMERICA INC6$4.8MQ4 2023Q3 2024yes
ASTRAZENECA PHARMACEUTICALS LPW STRATEGIES, LLC5$0Q3 2023Q3 2024—
DAIICHI SANKYO INC5$1.5MQ4 2023Q3 2024yes
GSK (FKA GLAXOSMITHKLINE INC.)5$6.3MQ4 2023Q3 2024yes
HEALTHCARE INSTITUTE OF NEW JERSEY5$274KQ4 2023Q3 2024yes
JOHNSON & JOHNSON SERVICES INC5$8.9MQ4 2023Q3 2024yes
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC5$620KQ3 2023Q3 2024yes
AARP4$19.9MQ1 2024Q3 2024yes
AMGEN INC4$11.6MQ1 2024Q3 2024yes
BIOTECHNOLOGY INNOVATION ORGANIZATIONAVOQ, LLC4$0Q1 2024Q3 2024yes
JAZZ PHARMACEUTICALS, INC.4$2.0MQ1 2024Q3 2024yes
LUNDBECK LLC4$550KQ1 2024Q3 2024yes
NEUROCRINE BIOSCIENCES, INC4$3.3MQ1 2024Q3 2024yes
NOVARTIS, INC.TODD STRATEGY GROUP4$0Q1 2024Q3 2024yes
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICATHE MCMANUS GROUP4$0Q3 2023Q3 2024yes
TAKEDA PHARMACEUTICALS AMERICA, INC.CROSSROADS STRATEGIES, LLC4$0Q1 2024Q3 2024yes
UCB, INC.4$1.1MQ1 2024Q3 2024yes
ALEXION PHARMACEUTICALS, INC.TODD STRATEGY GROUP3$240KQ4 2024Q3 2024yes